Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Burkitt Lymphoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Down Syndrome 2Lymphoma, Extranodal NK-T-Cell 1Leukemia, Biphenotypic, Acute 1

Interventions

Whole-Body Irradiation 4Specimen Handling 4Cytarabine 4Cyclophosphamide 4fludarabine 3venetoclax 2merphos 2fludarabine phosphate 2calaspargase pegol 2blinatumomab 2Stem Cell Transplantation 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Mycophenolic Acid 2Methotrexate 2Magnetic Resonance Spectroscopy 2Leucovorin 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Biopsy 2Asparaginase 2uproleselan 1treosulfan 1prednylidene 1pegaspargase 1midostaurin 1gilteritinib 1exifone 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Biphenotypic, Acute × pegaspargase × 30 days × Clear all
NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Children's Oncology Group

Phase 3 Active not recruiting
440 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡